BIT’s 9th Annual World Cancer Congress -2016 (WCC-2016) will be held on 14-16, May 2016 in Shanghai, China.
WCC-2016 provides a unique and ideal opportunity for a broad spectrum of researchers, clinicians and other health professionals to meet, discuss, share, learn and connect in order to find solutions to reduce the impact of cancer in the world. With the participation of outstanding international experts, we hope productive discussions would stimulate new creative ideas to translate new discoveries into better diagnosis and treatment of cancer patients.
WCC-2016 enables presenters and delegates to enjoy the state of the art oral and poster presentations covering the in-depth findings into the cause and processes of the disease and recent advances in clinical practice, from prevention to diagnosis, treatment and care.
We hope your participation would contribute to your professional development and relationships. Wish you enjoy the conference.
|Dr. Thomas Tursz, Professor & Honorary Director, Institut Gustave Roussy, France
||Dr. Vladimir LAZAR, Founder and Chief Operating Officer, WIN consortium, France||Dr. Alexandra Levine, Chief Medical Officer, Melinda and Norman Payson Professor of Medicine and Professor of Hematology/Transplantation, City of Hope National Medical Center, USA|
|Dr. Ivan Gout, Professor, University College London, UK||Dr. Gerd Birkenmeier, Professor, Institute of Biochemistry, University of Leipzig, Germany||Dr. Robert T Chatterton, Professor, Northwestern University Feinberg School of Medicine, USA|
|Dr. Adhip P. N. Majumdar, Professor & Senior Research Scientist, VA Medical Center/Karmanos Cancer Institute, Wayne State University, USA||Dr. Rajesh C. Shrotriya, CEO, Spectrum Pharmaceuticals, Inc., USA||Dr. Wim Vanden Berghe, Professor, University Antwerp, Belgium|
|Dr. Andreas Mandelis, Professor and Director, University of Toronto, Canada||Dr. Senyon Choe, Professor of Biology, University of California San Diego, USA||Dr. Belamy Cheung, Manager & Senior Lecturer, Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Australia|
|Dr. Mohamed Aziz, Senior Attending Pathologist/Cytopathologist, North Shore-LIJ Health System, Hofstra North Shore-LIJ School of Medicine, USA||Dr. Gian Otto Heinrich Dorta, Professor, CHUV, University Hospital of Lausanne, Switzerland||Dr. Antonia Dimitrakopoulou-Strauss, Deputy Head, Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Germany|
|Dr. Xaveer Van Ostade, Professor, Departement of Biomedical Sciences, University of Antwerp, Belgium||Dr. Johannes Haybaeck, Professor, Institute of Pathology, Medical University of Graz, Austria||Dr. Reza-Thierry ELAIDI, Director of Clinical Operations, ARTIC, France|
|Dr. Thomas Grundström, Professor, Department of Molecular Biology, Umeå University, Sweden||Dr. Manfred George Krukemeyer, Chairman, Department of Radio-Oncology, Paracelsus-Hospital, Germany||Dr. Arun K. Rishi, Professor, Department of Oncology, Karmanos Cancer Institute, Wayne State University, USA|
|Dr. Olivier Pardo, Team Leader & Lecturer, Division of Cancer, Imperial College, UK||Ms. Donna M. O’Brien, President and CEO, Strategic Visions in Healthcare, LLC., USA||Dr. K.S. Rangappa, Professor of Chemistry & Vice-Chancellor, University of Mysore Crawford Hall, India|
|Dr. Renata Pasqualini, Professor of Internal Medicine & Associate Director, Translational Research, University of New Mexico Cancer Center, USA||Dr. Qian-Yun Zhang, Professor of Pathology, University of New Mexico, USA||Dr. Xiaoyan Jiang, Professor, Medical Genetics, University of British Columbia & Distinguished Scientist, Terry Fox Laboratory, BC Cancer Research Centre, Canada|
|Dr. Vikash Sewram, Director & Professor, African Cancer Institute & Stellenbosch University, South Africa||Dr. Yanping Zhang, Professor, The University of North Carolina at Chapel Hill, USA||Dr. Yi Charlie Chen, Professor of Biology, Alderson Broaddus University, USA|
As part of the 2016 World Cancer Congress, an exhibition space will provide a unique opportunity for exhibitors to showcase their products and services to participants with interests in all areas of cancer. Developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent and repeated opportunities for delegates to visit the exhibits.
• The exhibition will be visited by participants of the conference it means by your authentic target group from China and other countries.
• The exhibitors have the opportunity to present their exhibits more detailed, and have the opportunity for longer discussion with inquiring visitors – in most cases specialists – than during session discussions.
Information Research Center of International Talents, SAFEA
BIT Congress Inc.
Foreign Experts Databank of SAFEA-Dalian Branch
Dr. Thomas Tursz
Professor & Honorary Director
Institut Gustave Roussy, France
Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2014-2015 BIT Congress Inc.